IPO registrations (S-1, F-1) · Registrants

Lite Strategy, Inc.

SEC CIK
1262104 · filings on EDGAR ↗
Name on the registration
MARSHALL EDWARDS INC
Former names
MEI Pharma, Inc. (2012–2025); MARSHALL EDWARDS INC (2003–2012)
Registration
Form S-1, first filed 2003-09-25, last 2012-03-20; 2 initial registrations, 4 amendments
Outcome
Final prospectus filed 2003-12-18; declared effective 2006-09-05
Industry (SIC)
Finance Services 6199
Incorporated in
DE
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 150, San Diego, CA 92121
EIN
51-0407811
Ticker
LITS (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
Lite Strategy, Inc. on the corporate pages

Offering terms

Proposed price range
$4.50–$6.50 per share (S-1/A filed 2003-12-10)
Final price
$9.00 per share, above the range (424B4 filed 2003-12-18, an initial public offering)
Listing
Nasdaq under the symbol MSHL
Lead underwriters
Janney Montgomery Scott

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 19

FiledFormWhat it isName as filedEDGAR
2003-09-25S-1S-1 (registration)MARSHALL EDWARDS INC0000950123-03-010789 ↗
2003-10-31S-1/AS-1/A (amendment)MARSHALL EDWARDS INC0000950123-03-012005 ↗
2003-11-26S-1/AS-1/A (amendment)MARSHALL EDWARDS INC0000950123-03-013228 ↗
2003-12-10S-1/AS-1/A (amendment)MARSHALL EDWARDS INC0000950123-03-013639 ↗
2003-12-18S-1MEFS-1MEF (added securities)MARSHALL EDWARDS INC0000950123-03-013918 ↗
2003-12-18424B4424B4 (final prospectus)MARSHALL EDWARDS INC0000950123-03-013919 ↗
2006-09-05EFFECTEFFECT (declared effective)MARSHALL EDWARDS INC9999999995-06-001426 ↗
2007-10-19EFFECTEFFECT (declared effective)MARSHALL EDWARDS INC9999999995-07-004153 ↗
2008-04-03EFFECTEFFECT (declared effective)MARSHALL EDWARDS INC9999999995-08-000984 ↗
2011-03-07EFFECTEFFECT (declared effective)MARSHALL EDWARDS INC9999999995-11-000611 ↗
2011-05-26EFFECTEFFECT (declared effective)MARSHALL EDWARDS INC9999999995-11-001669 ↗
2011-08-15EFFECTEFFECT (declared effective)MARSHALL EDWARDS INC9999999995-11-002500 ↗
2012-02-21S-1S-1 (registration)MARSHALL EDWARDS INC0001193125-12-068642 ↗
2012-03-20S-1/AS-1/A (amendment)MARSHALL EDWARDS INC0001193125-12-122620 ↗
2012-03-26EFFECTEFFECT (declared effective)MARSHALL EDWARDS INC9999999995-12-000834 ↗
2012-11-08EFFECTEFFECT (declared effective)MEI Pharma, Inc.9999999995-12-003197 ↗
2013-01-14EFFECTEFFECT (declared effective)MEI Pharma, Inc.9999999995-13-000178 ↗
2013-01-29EFFECTEFFECT (declared effective)MEI Pharma, Inc.9999999995-13-000318 ↗
2013-11-21EFFECTEFFECT (declared effective)MEI Pharma, Inc.9999999995-13-003334 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2003-12-10S-1/Aregistration statement$4.50–$6.50--Nasdaq MSHL1primary document; range, cover names 1document ↗
2003-12-18424B4final prospectus$9.00--Nasdaq MSHL1primary document; price line, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Williams BryanDirector52006–2012
Rueckert William DodgeDirector192008–2019
NAUGHTON CHRISTOPHERDirector,OfficerCEO & President12008
SEATON DAVID ROfficerCFO & Secretary12008
NOVOGEN LTDTenPercentOwner72008–2012
JOHNSTON PHILIP ADirector12009
GOLD DANIEL P PHDDirector; Director,OfficerChief Executive Officer; President and Chief Executive262010–2023
Zech Thomas M.OfficerChief Financial Officer92010–2016
White Christine AnnaDirector152010–2022
Mass Robert D.OfficerChief Medical Officer152011–2020
Baltic Charles V. IIIDirector282011–2023
Cann Leah RushDirector82011–2016
AUSTIN JOSIAH TTenPercentOwner32012
El Coronado Holdings, LLCTenPercentOwner22012
Vivo Ventures Fund VII, L.P.TenPercentOwner62012–2013
Vivo Ventures Fund V, L.P.TenPercentOwner62012–2013
Vivo Ventures V Affiliates Fund, L.P.TenPercentOwner62012–2013
Vivo Ventures VII Affiliates Fund, L.P.TenPercentOwner62012–2013
VIVO VENTURES VII, LLCTenPercentOwner82012–2015
Vivo Ventures V, LLCTenPercentOwner82012–2015
AKKARAJU SRINIVASTenPercentOwner22012–2013
Chambon Philippe O.TenPercentOwner72012–2015
Delagardelle JeaniTenPercentOwner72012–2015
HUNT RONALDTenPercentOwner72012–2015
Lathi Vijay KTenPercentOwner72012–2015
New Leaf Venture Associates II, L.P.TenPercentOwner72012–2015
New Leaf Venture Management II, L.L.C.TenPercentOwner72012–2015
New Leaf Ventures II, L.P.TenPercentOwner72012–2015
NIEDEL JAMESTenPercentOwner52012–2013
Reynolds Thomas CDirector152013–2025
Glover NicholasDirector152013–2025
Ratcliffe LiamTenPercentOwner32013–2015
Urso David MDirector,Officer; OfficerChief Operating Officer & GC; President and CEO; Sr. V.P. and General Counsel; Sr. V.P. & General Counsel152014–2023
Clemens KevanDirector92014–2021
Drazba Brian G.OfficerChief Financial Officer102017–2022
DRISCOLL FREDERICK WDirector122018–2025
HOWSON TAMAR DDirector62019–2023
Cohen CherylDirector52020–2022
GHALIE RICHARD GOfficerChief Medical Officer52021–2023
KANGO SUJAYDirector42021–2023
Anson Advisors Inc.TenPercentOwner52023
Anson Funds Management LPTenPercentOwner52023
Anson Management GP LLCTenPercentOwner52023
Cable Car Capital LLCTenPercentOwner52023
Funicular Funds, LPTenPercentOwner52023
Kassam MoezTenPercentOwner52023
Ma-Weaver JacobTenPercentOwner52023
Nathoo AminTenPercentOwner52023
Winson Bruce RossTenPercentOwner52023
File Justin J.Director,Officer; OfficerCEO, CFO and Secretary; CFO and Corporate Secretary; Secretary, Acting CEO & CFO52023–2026
Flynn James PDirector102023–2026
Datoo TaheerDirector12023
Wood Steven DDirector52023–2025
Lee Charles BenjaminDirector22025person page Fuzzy
Riezman JoshuaDirector32025
Schornstein AlexanderTenPercentOwner22025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2018-05-30MEI Pharma, Inc.Pharmaceuticals$74,999,990$74,999,990201

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerMEI Pharma, Inc.CAForm D private offeringsCIK (EXACT)
SEC filerLite Strategy, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerLite Strategy, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorMEI PHARMA, INCEIN (EXACT)
Person pageCharles Benjamin LeePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Finance Services, CA first:

More with this interest.

In other datasets, the same topic (Finance) in CA:

Interests: Finance Services · Finance